Exosens Forecast, price target & analysts
Exosens Target price 2026 - Analyst rating & recommendation
Exosens Classifications & Recommendation
Exosens Price Target
| Target Price | €66.81 |
| Price | €60.65 |
| Potential |
10.16%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Exosens 2027 .
The average Exosens target price is €66.81.
This is
10.16%
register free of charge
€78.75
29.84%
register free of charge
€59.89
1.25%
register free of charge
|
|
| A rating was issued by 19 analysts: 15 Analysts recommend Exosens to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Exosens stock has an average upside potential 2027 of
10.16%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 468.19 | 555.37 |
| 22.10% | 18.62% | |
| EBITDA Margin | 30.98% | 31.84% |
| 11.11% | 2.78% |
14 Analysts have issued a sales forecast Exosens 2026 . The average Exosens sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Exosens EBITDA forecast 2026. The average Exosens EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.84 | 1.76 |
| 15.07% | 109.52% | |
| P/E | 34.48 | |
| EV/Sales | 5.76 |
14 Analysts have issued a Exosens forecast for earnings per share. The average Exosens EPS is
This results in the following potential growth metrics and future valuations:
Current Exosens Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jul 12 2026 |
| TP ICAP |
Locked
➜
Locked
|
Locked | Jun 28 2026 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Jun 24 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jun 23 2026 |
| MIDCAP PARTNERS |
Locked
➜
Locked
|
Locked | Mar 03 2026 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Mar 02 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Mar 02 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jul 12 2026 |
|
Locked
TP ICAP:
Locked
➜
Locked
|
Jun 28 2026 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Jun 24 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jun 23 2026 |
|
Locked
MIDCAP PARTNERS:
Locked
➜
Locked
|
Mar 03 2026 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Mar 02 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 02 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
